- Home
- RVMD vs ZM Comparison
RVMD vs ZM Comparison
Compare RVMD & ZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | ZM |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 26.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | RVMD | ZM |
|---|---|---|
| Price | $140.70 | $96.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 22 |
| Target Price | ★ $140.84 | $94.14 |
| AVG Volume (30 Days) | 3.8M | ★ 3.8M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.52 |
| EPS | N/A | ★ 6.18 |
| Revenue | N/A | ★ $4,868,769,000.00 |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | $533.02 | $3.96 |
| P/E Ratio | ★ N/A | $14.77 |
| Revenue Growth | N/A | ★ 4.36 |
| 52 Week Low | $34.00 | $69.15 |
| 52 Week High | $155.70 | $97.58 |
Technical Indicators
Market Signals| Indicator | RVMD | ZM |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 70.17 |
| Support Level | $93.39 | $79.55 |
| Resistance Level | $155.70 | $97.05 |
| Average True Range (ATR) | 7.53 | 3.86 |
| MACD | -0.07 | 0.76 |
| Stochastic Oscillator | 75.43 | 99.87 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About ZM Zoom Video Communications Inc.
Zoom Communications provides a video-first communications platform that connects people through frictionless video, voice, chat, and content sharing. The company's cloud-native platform enables video experiences and connects users across various devices and locations in a single meeting. Zoom has launched a variety of communications-related solutions, including Zoom Phone and Zoom Contact Center. The firm was founded in 2011 and serves companies of all sizes from all industries around the world.